Augmentation of Transport for Cisplatin-Glutathione Adduct in Cisplatin-resistant Cancer Cells

Cancer Research

Volumn 55, Issue 19, 1995, Pages 4297-4301

  Goto, Shinji ^a   Morikawa, Tooru ^a   Urata, Yoshishige ^a   Kondo, Takahito ^a   Yoshida, Kazuhiro ^b   Suzuki, Keiichiro ^c  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GLUTATHIONE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; DRUG RESISTANCE; DRUG TRANSPORT; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CISPLATIN; DRUG RESISTANCE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HUMAN; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0029078644     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA, 89:3070–3074, 1992.
2. Hamilton, T. C., Winker, M. A., Louie, K. G., Batist, G., Behrens, B. C., Tsuruo, T., Grotzinger, K. R., Mckoy, W. M., Young, R. C., and Ozols, R. F. Augmentation of Adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem. Pharmacol., 34:2583–2586, 1985.
3. Richon, V. M., Schulte, N., and Eastman, A. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia LI 210 cells. Cancer Res., 47:2056–2061, 1987.
4. Meijer, C., Mulder, N. H., Hospers, G. A. P., Uges, D. R. A., and de Vries, E. G. E. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br. J. Cancer, 62:72–77, 1990.
5. Nakagawa, K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Sato, K., Terada, M., and Kenneth, D. T. Glutathione 5-transferase 7r as a determinant of drug resistance in transfectant cell line. J. Biol. Chem., 265:4296–4301, 1990.
6. Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C., Cucchi, C. A., Rosowsky, A., Henner, W. D., and Frei, E., III. Characterization of a human squamous carcinoma cell line resistant to c/.v-diamminedichloroplatinum(II). Cancer Res., 47:388–393, 1987.
7. Bungo, M., Fujiwara, Y., Kasahara, K., Nakagawa, K., Ohe, Y., Sasaki, Y., Irino, S., and Saijo, N. Decreased accumulation as a mechanism of resistance to cw-diam-minedichloroplatinum(II) in human non-small cell lung cancer cell lines:relation to DNA damage and repair. Cancer Res., 50:2549–2553, 1990.
8. Andrews, P. A., Velury, S., Mann, S. C., and Howell, S. B. m-Diamminedichloro-platinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48:68–73, 1988.
9. Hospers, G. A. P., Mulder, N. H., de Jong, B., de Ley, L., Uges, D. R. A., Fichtinger-Schepman, A. M. J., Scheper, R. J., and de Vries, E. G. E. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Cancer Res., 48:6803–6807, 1988.
10. Timmer-Bosscha, H., Timmer, A., Meijer, C., de Vries, E. G. E., de Jong, B., Oosterhuis, J. W., and Mulder, N. H. cis-Diamminedichloroplatinum(II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res., 53:5707–5713, 1993.
11. Bailey, H. H., Gipp, J. J., Ripple, M., Wilding, G., and Mulcahy, R. T. Increase in 7-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res., 52:5115–5118, 1992.
12. Green, J. A., Vistica, D. T., Young, R. C., Hamilton, T. C., Rogan, A. K., and Ozols, R. F. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res., 44:5427–5431, 1984.
13. Moore, W. R., Anderson, M. E., Meister, A., Murata, M., and Kimura, A. Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli:a possible model for mammalian cell protection. Proc. Natl. Acad. Sci. USA, 86:1461–1464, 1989.
14. Meister, A. Selective modification of glutathione metabolism. Science (Washington DC), 220:472–477, 1983.
15. Board, P. G. Transport of glutathione 5-conjugate from human erythrocytes. FEBS Lett., 124:163–165, 1981.
16. Ishikawa, T., and Sies, H. Cardiac transport of glutathione disulfide and 5-conjugate. J. Biol. Chem., 259:3838–3843, 1984.
17. Kobayashi, K., Sogame, Y., Hara, H., and Hayashi, K. Mechanism of glutathione 5-conjugate transport in canalicular and basolateral rat liver plasma membranes. J. Biol. Chem., 265:7737–7741, 1990.
18. Kondo, T., Murao, M., and Taniguchi, N. Glutathione 5-conjugate transport using inside-out vesicles from human erythrocytes. Eur. J. Biochem., 125:551–554, 1982.
19. Ishikawa, T. The ATP-dependent glutathione 5-conjugate export pump. Trends Biochem. Sci., 17:463–468, 1992.
20. Ishikawa, T., and Ali-Osman, F. Glutathione-associated cu-diamminedichloroplati-num(II) metabolism and ATP-dependent efflux from leukemia cells. J. Biol. Chem., 268:20116–20125, 1993.
21. Odenheimer, B., and Wolf, W. Reactions of cisplatin with sulfur-containing amino acids and peptides. I. Cysteine and glutathione. Inorg. Chim. Acta, 66:L41-L43, 1982.
22. Ishikawa, T. “GS-X pump” is functionally overexpressed in cisplatin-resistant human leukemia cells. Proc. Am. Assoc. Cancer Res., 35:376, 1994.
23. Ishikawa, T., Wright, C. D., and Ishizuka, H. GS-X pump is functionally overexpressed in c/s-diammine dichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem., 269:29085–29093, 1994.
24. Beutler, E., and Gelbart, T. Improved assay of the enzymes of glutathione synthesis:7-glutamylcysteine synthetase and glutathione synthetase. Clin. Chim. Acta, 158:115–123, 1986.
25. Beutler, E. A manual of biochemical methods. In:E. Beutler (ed.), Red Cell Metabolism, Ed. 3, pp. 77–136. Orlando, FL:Grune and Stratton, 1984.
26. Kondo, T., Yoshida, K., Urata, Y., Goto, S., Gasa, S., and Taniguchi, N. y-Glutamyl-cysteine synthetase and active transport of glutathione 5-conjugate are responsive to heat shock in K562 erythroid cells. J. Biol. Chem., 268:20366–20372, 1993.
27. Amemiya, Y., and Miyahara, J. Imaging plate illuminates many fields. Nature (Lond.), 336:89–90, 1988.
28. Redinbaugh, M. G., and Turley, R. B. Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Anal. Biochem., 153:267–271, 1986.
29. Siddik, Z. H., Boxall, F. E., and Harrap, K. R. Flameless atomic absorption spectro-photometric determination of platinum in tissues solubilized in hyamine hydroxide. Anal. Biochem., 163:21–26, 1987.
30. Mosmann, T. Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65:55–63, 1983.
31. Wahllander, A., and Sies, H. Glutathione 5-conjugate formation from l-chloro-2, 4-dinitrobenzene and biliary 5-conjugate excretion in the perfused rat liver. Eur. J. Biochem., 96:441–446, 1979.
32. Scanlon, K. J., Newman, E. M., Lu, Y., and Priest, D. G. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc. Natl. Acad. Sci. USA, 83:8923–8925, 1986.
33. Chu, G. Cellular responses to cisplatin. J. Biol. Chem., 269:787–790, 1994.
34. Kondo, T., Kawakami, Y., Taniguchi, N., and Beutler, E. Glutathione disulfide-stimulated Mg2+-ATPase of human erythrocyte membranes. Proc. Natl. Acad. Sci. USA, 84:7373–7377, 1987.